Info
Accuracy of drug categorizations for Medicaid rebates
| Accuracy of drug categorizations for Medicaid rebates |
| Pubbl/distr/stampa | [Washington, D.C.] : , : Department of Health and Human Services, Office of Inspector General, , 2009 |
| Descrizione fisica | 1 online resource (iv, 21 pages) : illustrations |
| Soggetto topico |
Medicare beneficiaries
Health insurance claims - United States Drugs - United States Rebates - United States Pharmaceutical policy - United States |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Accuracy of drug categorizations for Medicaid rebates |
| Record Nr. | UNINA-9910707236903321 |
| [Washington, D.C.] : , : Department of Health and Human Services, Office of Inspector General, , 2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Advance data from Vital and health statistics: numbers 171-180
| Advance data from Vital and health statistics: numbers 171-180 |
| Pubbl/distr/stampa | Hyattsville, Maryland : , : U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Center for Health Statistics, , 1995 |
| Descrizione fisica | 1 online resource (various pagings) : illustrations |
| Collana |
Vital and health statistics. Series 16, Compilations of advance data from vital and health statistics
DHHS publication |
| Soggetto topico |
AIDS (Disease) - United States
Cardiovascular system - Diseases - United States Drugs - United States Death - United States - Causes Health surveys - United States |
| Soggetto genere / forma | Statistics. |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | No. 171. Office visits to cardiovascular disease specialists, 1985 -- no. 172. Characteristics of persons dying of diseases of heart: preliminary data from the 1986 National Mortality Followback Survey -- no. 173. Characteristics of persons dying from AIDS -- no. 174. Use of vitamin and mineral supplements in the United States: current users, types of products, and nutrients -- no. 175. AIDS knowledge and attitudes for December 1988 -- no. 176. AIDS knowledge and attitudes for January-March 1989 -- no. 177. Utilization of controlled drugs in office-based ambulatory care: National Ambulatory Medical Care Survey, 1985 -- no. 178. Firearm mortality among children and youth -- no. 179. AIDS knowledge and attitudes for April-June 1989 -- no. 180. Characteristics of persons dying from cerebrovascular diseases. |
| Altri titoli varianti | Advance data from Vital and health statistics |
| Record Nr. | UNINA-9910709988803321 |
| Hyattsville, Maryland : , : U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Center for Health Statistics, , 1995 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Availability of Medicare part D drugs to dual-eligible nursing home residents
| Availability of Medicare part D drugs to dual-eligible nursing home residents |
| Pubbl/distr/stampa | Washington, D.C. : , : Department of Health and Human Services, Office of Inspector General, , 2008 |
| Descrizione fisica | 1 online resource (v, 28 pages) : illustrations |
| Soggetto topico |
Medicare beneficiaries - Services for
Medicaid beneficiaries - Services for Nursing home residents - United States Drugs - United States |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Availability of Medicare part D drugs to dual-eligible nursing home residents |
| Record Nr. | UNINA-9910707726103321 |
| Washington, D.C. : , : Department of Health and Human Services, Office of Inspector General, , 2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Blockbuster drugs : the rise and fall of the pharmaceutical industry / / Jie Jack Li
| Blockbuster drugs : the rise and fall of the pharmaceutical industry / / Jie Jack Li |
| Autore | Li Jie Jack |
| Pubbl/distr/stampa | Oxford ; ; New York : , : Oxford University Press, , [2014] |
| Descrizione fisica | 1 online resource (238 p.) |
| Disciplina | 338.4/76151 |
| Collana | Oxford scholarship online |
| Soggetto topico |
Drugs - United States
Pharmaceutical industry - United States - History |
| Soggetto genere / forma | Electronic books. |
| ISBN |
0-19-756301-5
0-19-991192-4 0-19-990904-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Machine generated contents note: -- Table of Contents Chapter 1 Before the Age of Blockbuster Drugs Chapter 2 The Beginning of an Era - The First Blockbuster Drug Tagamet Chapter 3 More Blockbuster Drugs for Ulcer Chapter 4 Antihistamines as Allergy Medicines Chapter 5 Blood Thinners, From Heparin to Plavix Chapter 6 Conquest of Pain--Analgesics: from Morphine to Lyrica Chapter 7 Lessons Bibliography Appendix Index. |
| Record Nr. | UNINA-9910453771703321 |
Li Jie Jack
|
||
| Oxford ; ; New York : , : Oxford University Press, , [2014] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Blockbuster drugs : the rise and fall of the pharmaceutical industry / / Jie Jack Li
| Blockbuster drugs : the rise and fall of the pharmaceutical industry / / Jie Jack Li |
| Autore | Li Jie Jack |
| Pubbl/distr/stampa | Oxford ; ; New York : , : Oxford University Press, , [2014] |
| Descrizione fisica | 1 online resource (238 p.) |
| Disciplina | 338.4/76151 |
| Collana | Oxford scholarship online |
| Soggetto topico |
Drugs - United States
Pharmaceutical industry - United States - History |
| ISBN |
0-19-756301-5
0-19-991192-4 0-19-990904-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Machine generated contents note: -- Table of Contents Chapter 1 Before the Age of Blockbuster Drugs Chapter 2 The Beginning of an Era - The First Blockbuster Drug Tagamet Chapter 3 More Blockbuster Drugs for Ulcer Chapter 4 Antihistamines as Allergy Medicines Chapter 5 Blood Thinners, From Heparin to Plavix Chapter 6 Conquest of Pain--Analgesics: from Morphine to Lyrica Chapter 7 Lessons Bibliography Appendix Index. |
| Record Nr. | UNINA-9910790780603321 |
|
Li Jie Jack
|
||
| Oxford ; ; New York : , : Oxford University Press, , [2014] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Description and analysis of the VA National Formulary [[electronic resource] /] / David Blumenthal and Roger Herdman, editors ; VA Pharmacy Formulary Analysis Committee, Division of Health Care Services, Institute of Medicine
| Description and analysis of the VA National Formulary [[electronic resource] /] / David Blumenthal and Roger Herdman, editors ; VA Pharmacy Formulary Analysis Committee, Division of Health Care Services, Institute of Medicine |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, c2000 |
| Descrizione fisica | xvi, 262 p. : ill |
| Altri autori (Persone) |
BlumenthalDavid <1948->
HerdmanRoger |
| Soggetto topico |
Drugs - United States
Drug utilization - Government policy - United States Medicine Veterans - Medical care - United States - Quality control |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-18551-1
9786610185511 0-309-56964-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910456345303321 |
| Washington, D.C., : National Academy Press, c2000 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Description and analysis of the VA National Formulary / / David Blumenthal and Roger Herdman, editors ; VA Pharmacy Formulary Analysis Committee, Division of Health Care Services, Institute of Medicine
| Description and analysis of the VA National Formulary / / David Blumenthal and Roger Herdman, editors ; VA Pharmacy Formulary Analysis Committee, Division of Health Care Services, Institute of Medicine |
| Pubbl/distr/stampa | Washington, D.C. : , : National Academy Press, , 2000 |
| Descrizione fisica | xvi, 262 pages : illustrations |
| Altri autori (Persone) |
BlumenthalDavid <1948->
HerdmanRoger |
| Soggetto topico |
Drugs - United States
Drug utilization - Government policy - United States Medicine Veterans - Medical care - United States - Quality control |
| ISBN |
0-309-18353-7
1-280-18551-1 9786610185511 0-309-56964-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910778629803321 |
| Washington, D.C. : , : National Academy Press, , 2000 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Description and analysis of the VA National Formulary / / David Blumenthal and Roger Herdman, editors ; VA Pharmacy Formulary Analysis Committee, Division of Health Care Services, Institute of Medicine
| Description and analysis of the VA National Formulary / / David Blumenthal and Roger Herdman, editors ; VA Pharmacy Formulary Analysis Committee, Division of Health Care Services, Institute of Medicine |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, c2000 |
| Descrizione fisica | xvi, 262 pages : illustrations |
| Altri autori (Persone) |
BlumenthalDavid <1948->
HerdmanRoger |
| Soggetto topico |
Drugs - United States
Drug utilization - Government policy - United States Medicine Veterans - Medical care - United States - Quality control |
| ISBN |
9786610185511
9780309183536 0309183537 9781280185519 1280185511 9780309569644 0309569648 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
DESCRIPTION AND ANALYSIS OF THE VA National Formulary -- Copyright -- Preface -- REVIEWERS -- Contents -- Executive Summary -- SUMMARY AND CONCLUSIONS -- Restrictiveness -- Cost -- Quality -- Comparisons -- Recommendations -- 1 Introduction -- LEGISLATIVE AND EXECUTIVE BRANCH HISTORY -- History of the IOM Study -- The IOM Committee -- FORMULARIES AND FORMULARY SYSTEMS: HISTORY AND DEFINITIONS -- Modern Formularies and Formulary Systems -- Economic Focus of Formularies -- Types of Formularies and Their Restrictiveness -- Formulary Control -- GENERIC SUBSTITUTION -- THERAPEUTIC INTERCHANGE -- LOCAL VA FACILITY AND VISN FORMULARIES AND THE NATIONAL FORMULARY -- History of VA Formulary Management Prior to the National Formulary -- Reorganization of the VA -- Impact of the VA Fixed Budget -- Establishing the VA National Formulary -- Evolution of the National Formulary -- Medical Staff Input -- National Formulary Classes -- Formulary Relationship to Pharmaceutical Companies -- REPORT OUTLINE -- 2 Is the VA National Formulary Overly Restrictive and Does It Prevent Physicians from Meeting the Health Care Needs of… -- BACKGROUND -- Elements of Restrictiveness -- SIZE AND COVERAGE OF THE NATIONAL FORMULARY -- Adequacy of the VA National Formulary -- Closed and Preferred Drug Classes in the VA -- Restrictiveness of Class Closure -- Excluded Drugs and Other Limits -- National Formulary Effects on Drug Use -- ADDITION OF NEW DRUGS AND FORMULARY REAPPRAISAL -- National Policy Regarding New Drugs -- VISN Addition of New FDA Approvals -- Evaluation of the VA Process for Adding New FDA-Approved Priority Drugs -- Addition of Existing Drugs by the VA -- Addition of Newly Approved or Existing Drugs in Other Health Care Systems -- THE NONFORMULARY PROCESS -- THERAPEUTIC INTERCHANGE -- OTC DRUG COVERAGE, GENERIC SUBSTITUTION, AND PHYSICIAN SATISFACTION.
Generic Substitution -- Veterans' Complaints -- VA Physician Satisfaction -- SUMMARY -- 3 What Are the Potential Costs to VA Health Care Associated with the National Formulary for Drugs? -- INTRODUCTION -- THE VHA NATIONAL FORMULARY AS IT AFFECTS COSTS -- Background -- Basic Economics of the VA National Formulary -- Features of the National Formulary -- VISN Implementation Issues -- Other Influences on VHA Pharmaceutical Spending -- ANALYTICAL FRAMEWORK -- DATA -- EMPIRICAL METHODS -- RESULTS OF THE IOM COMMITTEE ANALYSIS OF COST EFFECTS -- How Have the VHA and the Veteran User Population Changed During the Study Period? -- How Has the National Formulary Affected Prices for Closed and Preferred Classes? -- How Has the National Formulary Affected Prescribing Patterns Within the Closed and Preferred Classes? -- How Has the National Formulary Affected Pharmaceutical Spending per Veteran User for Closed and Preferred Classes? -- IS THERE EVIDENCE THAT CHANGES IN FORMULARY POLICY HAVE RESULTED IN INCREASED UTILIZATION ELSEWHERE IN THE VHA SYSTEM? -- Exploration of Changes in Hospital Discharges per VHA User -- COSTS ASSOCIATED WITH IMPLEMENTING AND MANAGING THE NATIONAL FORMULARY -- Estimated National Formulary Savings -- CONCLUSIONS -- 4 What Are the Effects of the National Formulary and Related Policies on Quality of Care? -- BACKGROUND INFORMATION -- Sources of Quality Data -- QUALITY OF CARE IN THE VHA AND EFFECTS OF THE NATIONAL FORMULARY -- PHARMACY, CLINICAL, AND FORMULARY PROGRAM ELEMENTS RELEVANT TO QUALITY OF CARE -- Clinical Pharmacy -- P& -- T COMMITTEES -- THE VA PBM COMPLEX -- Additions to, and Quality of, the National Formulary -- POLICIES AND PROCEDURES -- Drug Class Reviews -- Clinical Guidelines and Drug Utilization Reviews -- The Nonformulary Process -- Therapeutic Interchange, Policy, and Results. EFFECTS OF THE NATIONAL FORMULARY ON USE OF DRUGS BY THE VA -- ADVERSE DRUG EVENTS -- Changes in Inpatient Hospital Discharges Associated with the National Formulary -- PATIENT COMPLAINTS-ADVOCATE, VETERANS OF FOREIGN WARS, AND SURVEY DATA -- PHYSICIAN COMPLAINTS AND SURVEY DATA -- SUMMARY STATEMENT -- 5 How Does the VA National Formulary Compare with Private Insurance Formularies for Drugs and Devices and with Other… -- INTRODUCTION -- IMPLEMENTATION OF DRUG MANAGEMENT STRATEGIES IN MANAGED CARE -- IMPACT OF STATE LEGISLATION ON MCO PRACTICE -- PUBLIC-SECTOR PROGRAMS -- Medicaid -- Medicaid Fee for Service -- Medicaid Prescription Drug Benefit -- Medicaid Controls Prior Approval and Formulary Systems -- Comparison to the VA -- Effects of Medicaid Formularies and Formulary Systems -- Effects of Medicaid Prior Approval Systems -- Effects of Medicaid Prescription Limits -- Medicaid Managed Care: Background -- Drug Benefit in Medicaid Managed Care -- DEPARTMENT OF DEFENSE -- Health Care System and Pharmacy Benefit -- DOD Formulary and Formulary System -- GENERAL COMMENTS ON COMPARISONS -- 6 The VA National Formulary and Veterans Health Care -- INTRODUCTION -- BACKGROUND AND CONTEXT -- THE VETERANS HEALTH ADMINISTRATION -- RESTRICTIVENESS -- COSTS -- QUALITY -- COMPARISONS -- References -- Acronyms -- APPENDIX A Interim Report of the Committee on VA Pharmacy Formulary Analysis to the Department of Veterans Affairs and the… -- JANUARY 28, 2000 -- APPENDIX B Academy of Managed Care Pharmacy's Managed Care Formulary and Pharmacy Benefit Design Survey -- AMCP MANAGED CARE FORMULARY AND PHARMACY BENEFIT DESIGN SURVEY (JANUARY 2000) -- The P& -- T Committee -- Exclusion of Coverage -- Closed Formularies -- Open-Preferred Formularies -- Open-Passive Formularies -- Other Types of Formularies -- Drug Restrictions -- Generic Drugs. Access to Nonformulary Drugs -- Cost-Containment Measures -- Addition of New FDA-Approved Drugs -- Appeals Process -- Continuation of Care -- APPENDIX C Additional Cost Information -- APPENDIX D Glossary -- APPENDIX E Drug Classes and Drug Index -- DRUG CLASSES -- OTHER DRUGS -- Committee Biographies. |
| Altri titoli varianti |
VA National Formulary
Veterans Administration National Formulary |
| Record Nr. | UNINA-9910957317403321 |
| Washington, D.C., : National Academy Press, c2000 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Drugs@FDA [[electronic resource]]
| Drugs@FDA [[electronic resource]] |
| Pubbl/distr/stampa | Washington D.C., : U.S. Food and Drug Administration, Center for Drug and Evaluation Research |
| Soggetto topico |
Drugs - United States
Drugs, Nonprescription - United States Drug approval - United States Pharmaceutical Preparations Drug Approval |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Drugs at FDA |
| Record Nr. | UNINA-9910693367803321 |
| Washington D.C., : U.S. Food and Drug Administration, Center for Drug and Evaluation Research | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Emerging health care issues [[electronic resource] ] : follow-on biologic drug competition : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, first session, June 11, 2009
| Emerging health care issues [[electronic resource] ] : follow-on biologic drug competition : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, first session, June 11, 2009 |
| Pubbl/distr/stampa | Washington : , : U.S. G.P.O., , 2012 |
| Descrizione fisica | 1 online resource (vi, 283 pages) : illustrations |
| Soggetto topico |
Biologicals - Government policy - United States
Pharmaceutical biotechnology - Government policy - United States Drugs - United States |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Emerging health care issues |
| Record Nr. | UNINA-9910703347403321 |
| Washington : , : U.S. G.P.O., , 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
